Bayer proposes 7.25 billion dollar plan to settle Roundup cancer claims

Bayer filed a proposal today to resolve claims that its Roundup weedkiller causes cancer. This plan establishes a long-term program funded over 21 years total.

The Monsanto unit of Bayer, which is headquartered in Germany DEDE, has filed a proposed class settlement in the United States USUS totaling as much as $7.25 billion. The filing was submitted to the Circuit Court of the City of St. Louis, Missouri, with the intention of resolving current and future claims that its Roundup (weedkiller) caused Non-Hodgkin lymphoma. This proposal is designed to address the majority of cases currently pending in U.S. state and federal courts.
The 120-meter-high Bayer Cross, the logo of German pharmaceutical and chemical maker Bayer AG consisting of 1,710 LED glass bulbs, is seen next to a red traffic light in Leverkusen, Germany, September 23, 2023. REUTERS/Wolfgang Rattay
The 120-meter-high Bayer Cross, the logo of German pharmaceutical and chemical maker Bayer AG consisting of 1,710 LED glass bulbs, is seen next to a red traffic light in Leverkusen, Germany, September 23, 2023. REUTERS/Wolfgang Rattay
IUX24

IUX24 提供深度財經、經濟與投資資訊,藉助 AI 發掘全球市場中最重要的信號。

IFZA Properties, Dubai Silicon Oasis, DSO-IFZA, Dubai, United Arab Emirates

Copyright IUX24 MEDIA - FZCO. 版權所有。

由 AI 驅動 • 精益求精

IUX24 是一個資訊與分析平台,提供新聞、市場數據、分析工具及 AI 驅動的功能,僅供資訊參考與教育用途。所提供的服務和資訊不構成投資建議、交易信號或經紀服務。投資涉及風險,用戶在作出投資決定前應審慎評估相關資訊。